연구성과로 돌아가기

2023 연구성과별 연구자 정보 (67 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone Kang, Seokjin Kang, S 5 교신저자 Keimyung Univ, Dept Pediat, Sch Med, Dongsan Hosp, 1095 Dalgubeol Daero, Daegu 42601, South Korea ksj@gw.kmu.ac.kr;
A Nullspace-Based Predictive Control Allocation for the Control of a Quadcopter Manipulating an Object Attached to the Ground Nguyen, Tam W. Nguyen, TW 1 교신저자 Univ Toyama, Dept Elect & Elect Engn, Toyama 9308555, Japan 0000-0002-0270-1199 Nguyen, Tam W. nguyen@eng.u-toyama.ac.jp;hirata@eng.u-toyama.ac.jp;kyoungsh@knu.ac.kr;
A Nullspace-Based Predictive Control Allocation for the Control of a Quadcopter Manipulating an Object Attached to the Ground Hirata, Kenji Hirata, K 2 Univ Toyama, Dept Elect & Elect Engn, Toyama 9308555, Japan L-2709-2018 Hirata, Kenji nguyen@eng.u-toyama.ac.jp;hirata@eng.u-toyama.ac.jp;kyoungsh@knu.ac.kr;
A Nullspace-Based Predictive Control Allocation for the Control of a Quadcopter Manipulating an Object Attached to the Ground Han, Kyoungseok Han, K 3 Kyungpook Natl Univ, Sch Mech Engn, Daegu 41566, South Korea nguyen@eng.u-toyama.ac.jp;hirata@eng.u-toyama.ac.jp;kyoungsh@knu.ac.kr;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Mak, Lung-Yi Mak, LY 1 Sch Clin Med, Dept Med, Hong Kong, Peoples R China ABB-1599-2020 Mak, Lung Yi (Loey) 0000-0002-2266-3935 Mak, Lung Yi mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Mak, Lung-Yi Mak, LY 1 Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Peoples R China ABB-1599-2020 Mak, Lung Yi (Loey) 0000-0002-2266-3935 Mak, Lung Yi mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Gane, Ed Gane, E 2 Univ Auckland, Auckland, New Zealand mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Schwabe, Christian Schwabe, C 3 New Zealand Clin Res, Auckland, New Zealand mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Yoon, Ki Tae Yoon, KT 4 Pusan Natl Univ, Coll Med, Dept Internal Med, Yangsan, South Korea mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Yoon, Ki Tae Yoon, KT 4 Pusan Natl Univ, Liver Ctr, Yangsan Hosp, Yangsan, South Korea mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Heo, Jeong Heo, J 5 Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea MHQ-1390-2025 Heo, Jeong 0000-0003-0961-7851 Heo, Jeong mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Heo, Jeong Heo, J 5 Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea MHQ-1390-2025 Heo, Jeong 0000-0003-0961-7851 Heo, Jeong mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Scott, Russell Scott, R 6 New Zealand Clin Res, Lipid & Diabet Res, Christchurch, New Zealand 0000-0002-2107-6480 Scott, Russell mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Lee, Jeong-Hoon Lee, JH 7 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea Q-1055-2018 Lee, Jeong-Hoon 0000-0002-0315-2080 Lee, Jeong-Hoon mfyuen@hku.hk;
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Lee, Jeong-Hoon Lee, JH 7 Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea Q-1055-2018 Lee, Jeong-Hoon 0000-0002-0315-2080 Lee, Jeong-Hoon mfyuen@hku.hk;
페이지 이동: